3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to sparse information suggesting unique biological properties. Present research suggest that 3-HPC may possess distinct impacts on the nervous structure, arguably influencing to some of the unexplained manifestations linked with PCP